Market Overview:
The global pharmaceutical gelatin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for hard capsules and soft capsules, rising prevalence of chronic diseases, and growing awareness about the benefits of using pharmaceutical gelatin. Based on type, the global pharmaceutical gelatin market is segmented into pig skin, bovine hides, bones, and others. Pig skin is expected to account for the largest share of this market in 2018 owing to its high availability and low cost. By application, hard capsules are expected to account for the largest share of this market in 2018 followed by soft capsules and micro-encapsulation. Hard capsules are used as a drug delivery system for delivering large doses of drugs whereas soft capsules are used as a drug delivery system for delivering small doses of drugs.
Product Definition:
A type of gelatin that is used in the pharmaceutical industry to make capsules, tablets and other solid dosage forms. It is also used as a stabilizer and thickener in many pharmaceutical products.
Pig Skin:
Pig skin is the outermost layer of the pig's body. It has been used as a raw material for making gelatin or pectin since ancient times. The growth factor in this market is increasing demand from end-use industries such as pharmaceutical, food & beverage and cosmetics among others which includes personal care products like skincare lotions and creams among many others.
Bovine Hides:
Bovine hides are the raw material used for manufacturing pharmaceutical grade gelatin. It is a by-product obtained during the processing of cattle skin and bones. Bovine hides are processed into gelatin, which is further utilized in various end-use industries such as food & beverage, personal care & cosmetics, pharmaceuticals and photography among others.
The global bovine hide market size was valued at USD 1.24 billion in 2016.
Application Insights:
The hard capsules segment led the global pharmaceutical gelatin market in 2017 and is projected to witness significant growth over the forecast period. The increasing use of gelatin capsules in nutritional & medical supplements, vitamins, minerals & dietary supplements industries is expected to drive demand for pharmaceutical-grade products over the coming years.
Soft capsules are used for a variety of applications including liquid medicines (in syrups, suspensions), solid oral formulations (dry powder medicine), and infant formula among others. Growing product demand from various application industries on account of its properties such as biodegradability and bio-absorbability is anticipated to fuel industry expansion over the coming years.
Pharmaceutical gelatins are used as excipients in drug delivery systems such as tablets, pills, caplets or film coatings owing to their high water solubility which helps deliver drugs along with other ingredients inside them.
Regional Analysis:
Asia Pacific is expected to be the fastest growing regional market with a CAGR of XX% from 2018 to 2030 owing to increasing product demand in various applications. The region accounts for approximately 60% of the global pharmaceutical industry and this trend is anticipated to continue over the forecast period, thereby augmenting market growth.
The presence of major players coupled with extensive R&D activities are some factors that can be attributed towards high product penetration in Asia Pacific region. In addition, rising healthcare expenditure by governments along with an increase in life expectancy has led to an increase in demand for pharmaceuticals which will further boost growth over the coming years.
Europe accounted for approximately 25% share of global revenue.
Growth Factors:
- Increasing demand for pharmaceuticals due to rising population and health awareness
- Growing use of gelatin in drug delivery systems and as a coating agent
- Rising demand from emerging markets
- Technological advancements in the pharmaceutical industry
- Increasing investment in research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Gelatin Market Research Report
By Type
Pig Skin, Bovine Hides, Bones, Others
By Application
Hard Capsules, Soft Capsules, Micro-encapsulation, Coating for Tablets, Absorbable Hemostat
By Companies
Rousselot, Tessenderlo Group, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Sterling Gelatin, Roxlor llc, Weishardt, Gelita AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Gelatin Market Report Segments:
The global Pharmaceutical Gelatin market is segmented on the basis of:
Types
Pig Skin, Bovine Hides, Bones, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hard Capsules, Soft Capsules, Micro-encapsulation, Coating for Tablets, Absorbable Hemostat
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Rousselot
- Tessenderlo Group
- Nitta Gelatin Inc.
- Capsugel
- Catelent Inc.
- Norland Products Inc
- Sterling Gelatin
- Roxlor llc
- Weishardt
- Gelita AG
Highlights of The Pharmaceutical Gelatin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pig Skin
- Bovine Hides
- Bones
- Others
- By Application:
- Hard Capsules
- Soft Capsules
- Micro-encapsulation
- Coating for Tablets
- Absorbable Hemostat
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Gelatin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical gelatin is a type of protein derived from the collagen found in animal skin and bones. Gelatin is used as a thickening agent, stabilizer, and emulsifier in pharmaceuticals. It can also be used to make capsules, tablets, and other medical products.
Some of the key players operating in the pharmaceutical gelatin market are Rousselot, Tessenderlo Group, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Sterling Gelatin, Roxlor llc, Weishardt, Gelita AG.
The pharmaceutical gelatin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Gelatin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Gelatin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Gelatin Market - Supply Chain
4.5. Global Pharmaceutical Gelatin Market Forecast
4.5.1. Pharmaceutical Gelatin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Gelatin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Gelatin Market Absolute $ Opportunity
5. Global Pharmaceutical Gelatin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Type
5.3.1. Pig Skin
5.3.2. Bovine Hides
5.3.3. Bones
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Gelatin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Application
6.3.1. Hard Capsules
6.3.2. Soft Capsules
6.3.3. Micro-encapsulation
6.3.4. Coating for Tablets
6.3.5. Absorbable Hemostat
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Gelatin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Gelatin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Gelatin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Application
9.4.1. Hard Capsules
9.4.2. Soft Capsules
9.4.3. Micro-encapsulation
9.4.4. Coating for Tablets
9.4.5. Absorbable Hemostat
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Type
9.7.1. Pig Skin
9.7.2. Bovine Hides
9.7.3. Bones
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Gelatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Application
10.4.1. Hard Capsules
10.4.2. Soft Capsules
10.4.3. Micro-encapsulation
10.4.4. Coating for Tablets
10.4.5. Absorbable Hemostat
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Type
10.7.1. Pig Skin
10.7.2. Bovine Hides
10.7.3. Bones
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Gelatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Application
11.4.1. Hard Capsules
11.4.2. Soft Capsules
11.4.3. Micro-encapsulation
11.4.4. Coating for Tablets
11.4.5. Absorbable Hemostat
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Type
11.7.1. Pig Skin
11.7.2. Bovine Hides
11.7.3. Bones
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Gelatin Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Gelatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Application
12.4.1. Hard Capsules
12.4.2. Soft Capsules
12.4.3. Micro-encapsulation
12.4.4. Coating for Tablets
12.4.5. Absorbable Hemostat
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Type
12.7.1. Pig Skin
12.7.2. Bovine Hides
12.7.3. Bones
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Gelatin Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Gelatin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Application
13.4.1. Hard Capsules
13.4.2. Soft Capsules
13.4.3. Micro-encapsulation
13.4.4. Coating for Tablets
13.4.5. Absorbable Hemostat
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Type
13.7.1. Pig Skin
13.7.2. Bovine Hides
13.7.3. Bones
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Gelatin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Gelatin Market: Market Share Analysis
14.2. Pharmaceutical Gelatin Distributors and Customers
14.3. Pharmaceutical Gelatin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Rousselot
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tessenderlo Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nitta Gelatin Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Capsugel
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Catelent Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Norland Products Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sterling Gelatin
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roxlor llc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Weishardt
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gelita AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook